Real-World Clinical Outcomes after Genomic Profiling of Circulating Tumor DNA in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer

Real-World Clinical Outcomes after Genomic Profiling of Circulating Tumor DNA in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer

Comprehensive genomic profiling for advanced non-small cell lung cancer (NSCLC) can identify patients for molecularly targeted therapies that improve clinical outcomes. We analyzed data from 3084 patients (median age 65 years, 72.9% with adenocarcinoma) with advanced NSCLC registered in a real-world...

Full description

Bibliographic Details
Main Authors: Steven Olsen, Jiemin Liao, Hidetoshi Hayashi
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Current Oncology
Subjects:
actionable alterations
comprehensive genomic profiling
ctDNA
non-small cell lung cancer
targeted therapy
Online Access:https://www.mdpi.com/1718-7729/29/7/382

Internet

https://www.mdpi.com/1718-7729/29/7/382

Similar Items